Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
2.120
-0.100 (-4.50%)
At close: Jun 27, 2025, 4:00 PM
2.150
+0.030 (1.42%)
After-hours: Jun 27, 2025, 7:57 PM EDT
Humacyte Market Cap
Humacyte has a market cap or net worth of $328.85 million as of June 27, 2025. Its market cap has decreased by -62.53% in one year.
Market Cap
328.85M
Enterprise Value
348.52M
1-Year Change
-62.53%
Ranking
Category
Stock Price
$2.12
Market Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $328.85M, an increase of 164.55%. That is a compound annual growth rate of 23.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 366.08M | -43.66% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | 130.74M | 5.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.37B |
| Johnson & Johnson | 366.73B |
| AbbVie | 324.08B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 280.05B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.40B |
| AstraZeneca | 215.99B |